| Metric | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue | 11.2B +2.2% | 11.0B -2.7% | 11.3B -9.2% | 12.4B +6.0% | 11.7B |
| Cost of Revenue | 6.4B +15.0% | 5.6B -17.3% | 6.7B -8.6% | 7.4B +8.9% | 6.8B |
| Gross Profit | 4.8B -11.0% | 5.4B +19.1% | 4.5B -10.2% | 5.0B +2.1% | 4.9B |
| Operating Expenses | 3.9B -4.2% | 4.1B +2.6% | 4.0B -1.5% | 4.0B +0.6% | 4.0B |
| R&D | 0 | 0 | 0 | 0 | 0 |
| SG&A | 3.9B -4.2% | 4.1B +2.6% | 4.0B -1.5% | 4.0B +0.6% | 4.0B |
| Operating Income | 888.0M -32.3% | 1.3B +137.1% | 553.0M -45.0% | 1.0B +8.5% | 927.0M |
| EBITDA | 1.1B -28.1% | 1.5B +103.8% | 738.0M -37.7% | 1.2B +6.1% | 1.1B |
| Net Income | 712.0M -33.4% | 1.1B +105.6% | 520.0M -34.3% | 792.0M +8.9% | 727.0M |
| EPS (Basic) | $0.48 -33.3% | $0.72 +105.7% | $0.35 -35.2% | $0.54 +10.2% | $0.49 |
| EPS (Diluted) | $0.48 -33.3% | $0.72 +105.7% | $0.35 -34.0% | $0.53 +8.2% | $0.49 |
| Shares (Diluted) | 1.5B +0.1% | 1.5B +0.1% | 1.5B +0.0% | 1.5B +0.1% | 1.5B |